| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| lercanidipine | voltage-gated calcium channel alpha-2/delta-1 | NA | Successful target | TTD , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Angina Pectoris[MeSHID:D000787] Raynaud Phenomenon[MeSHID:D011928] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.88 | approved | unknown |
| lercanidipine | voltage-dependent calcium channel gamma-1 subunit | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Angina Pectoris[MeSHID:D000787] Raynaud Phenomenon[MeSHID:D011928] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
6.12 | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||